These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 16792602

  • 41. Sublingual immunotherapy for allergic rhinitis: an update.
    Burastero SE.
    Curr Opin Otolaryngol Head Neck Surg; 2006 Jun; 14(3):197-201. PubMed ID: 16728900
    [Abstract] [Full Text] [Related]

  • 42. Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations.
    Cox L.
    Curr Allergy Asthma Rep; 2007 Nov; 7(6):410-20. PubMed ID: 17986370
    [Abstract] [Full Text] [Related]

  • 43. Sublingual immunotherapy in allergic rhinitis: indications, efficacy and safety.
    Kariyawasam HK, Rotiroti G, Robinson DS.
    Rhinology; 2013 Mar; 51(1):9-17. PubMed ID: 23441306
    [Abstract] [Full Text] [Related]

  • 44. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R, Saritzali G, Canakcioglu S.
    Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
    [Abstract] [Full Text] [Related]

  • 45. Sublingual immunotherapy in polysensitized allergic patients with rhinitis and/or asthma: allergist choices and treatment efficacy.
    Ciprandi G, Cadario G, Di Gioacchino M, Gangemi S, Minelli M, Ridolo E, Valle C, Verini M, Boccardo R, Incorvaia C, Puccinelli P, Scurati S, Frati F.
    J Biol Regul Homeost Agents; 2009 Jun; 23(3):165-71. PubMed ID: 19828093
    [Abstract] [Full Text] [Related]

  • 46. Efficacy of sublingual specific immunotherapy on allergic asthma and rhinitis in children's real life.
    De Castro G, Zicari AM, Indinnimeo L, Tancredi G, di Coste A, Occasi F, Castagna G, Giancane G, Duse M.
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2225-31. PubMed ID: 23893190
    [Abstract] [Full Text] [Related]

  • 47. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K, Gotoh M.
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [Abstract] [Full Text] [Related]

  • 48. Sublingual immunotherapy: factors influencing adherence.
    Bernaola G, Corzo JL, Domínguez-Ortega J, Lucas C, Ojeda I, Torres-Borrego J, ARIAL Group.
    J Investig Allergol Clin Immunol; 2012 Jun; 22(6):458-9. PubMed ID: 23101200
    [No Abstract] [Full Text] [Related]

  • 49. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C.
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [Abstract] [Full Text] [Related]

  • 50. Meta-analyses of specific immunotherapy trials.
    Calderon MA.
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
    [No Abstract] [Full Text] [Related]

  • 51. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with a 4-day shortened build-up phase.
    Giordano T, Quarta C, Bruno ME, Falagiani P, Riva G.
    Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):310-2. PubMed ID: 17191751
    [Abstract] [Full Text] [Related]

  • 52. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
    La Grutta S, Arena A, D'Anneo WR, Gammeri E, Leonardi S, Trimarchi A, Platania D, La Rosa M.
    Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
    [Abstract] [Full Text] [Related]

  • 53. Sublingual immunotherapy induces spirometric improvement associated with IL-10 production: preliminary reports.
    Ciprandi G, Cirillo I, Fenoglio D, Marseglia G, Tosca MA.
    Int Immunopharmacol; 2006 Aug; 6(8):1370-3. PubMed ID: 16782551
    [Abstract] [Full Text] [Related]

  • 54. [Sublingual immunotherapy (SLIT) in the allergologist's practice].
    Mösges R, Köberlein J, Keppler J.
    MMW Fortschr Med; 2008 Jun 26; 150 Suppl 2():79-84. PubMed ID: 18712127
    [No Abstract] [Full Text] [Related]

  • 55. Treating allergic rhinitis by sublingual immunotherapy: a review.
    Incorvaia C, Di Rienzo A, Celani C, Makrì E, Frati F.
    Ann Ist Super Sanita; 2012 Jun 26; 48(2):172-6. PubMed ID: 22751560
    [Abstract] [Full Text] [Related]

  • 56. Safety and tolerability of ultra-rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma.
    Gammeri E, Arena A, D'Anneo R, La Grutta S.
    Allergol Immunopathol (Madr); 2005 Jun 26; 33(4):221-3. PubMed ID: 16045861
    [Abstract] [Full Text] [Related]

  • 57. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses.
    Compalati E, Penagos M, Tarantini F, Passalacqua G, Canonica GW.
    Ann Allergy Asthma Immunol; 2009 Jan 26; 102(1):22-8. PubMed ID: 19205281
    [Abstract] [Full Text] [Related]

  • 58. Sublingual immunotherapy in youngsters: adherence in a randomized clinical trial.
    Röder E, Berger MY, de Groot H, Gerth van Wijk R.
    Clin Exp Allergy; 2008 Oct 26; 38(10):1659-67. PubMed ID: 18631346
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.